Pericyazine 10mg tablets

Land: Storbritannia

Språk: engelsk

Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiv ingrediens:

Pericyazine

Tilgjengelig fra:

Zentiva Pharma UK Ltd

ATC-kode:

N05AC01

INN (International Name):

Pericyazine

Dosering :

10mg

Legemiddelform:

Oral tablet

Administreringsrute:

Oral

Klasse:

No Controlled Drug Status

Resept typen:

Valid as a prescribable product

Produkt oppsummering:

BNF: 04020100; GTIN: 5000283653714

Informasjon til brukeren

PACKAGE LEAFLET:
INFORMATION FOR THE USER
PERICYAZINE 10MG TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE
YOU ARE GIVEN THIS MEDICINE BECAUSE
IT CONTAINS IMPORTANT INFORMATION FOR YOU.
 Keep this leaflet. You may need to read it again.
 If you have any further questions, ask your
doctor or pharmacist.
 This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them,
even if their symptoms are the same as yours.
 If you get any side effects, talk to your doctor
or pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
IN THIS LEAFLET:
1. What pericyazine is and what it is used for
2. Before you take pericyazine
3. How to take pericyazine
4. Possible side effects
5. How to store pericyazine
6. Further Information
1. WHAT PERICYAZINE IS AND WHAT IT IS USED FOR
The name of your medicine is Pericyazine
10mg Tablets (referred to as pericyazine
throughout this leaflet).This belongs to a group
of medicines called ‘phenothiazines’. It works
by blocking the effect of a chemical in the
brain. It can be used for:
 Schizophrenia
 The short term treatment of anxiety, agitation
and violent or dangerously impulsive
behaviour when used with other medicines
2. BEFORE YOU TAKE PERICYAZINE
DO NOT TAKE THIS MEDICINE AND TELL
YOUR DOCTOR IF:
 You are allergic (hypersensitive) to pericyazine
or any of the other ingredients in this
medicine (listed in Section 6)
Signs of an allergic reaction include: a rash,
swallowing or breathing problems, swelling
of your lips, face, throat or tongue
 You are pregnant, might become pregnant
or think you may be pregnant (see Section
below: ‘Pregnancy and breast-feeding’)
 You have urine retention due to a prostate
disorder
 You are taking a dopaminergic
antiparkinsonism drug
 You have increased pressure in the eye
(glaucoma)
 You have a history of a low white blood
cell count
 It is intended for a child younger than 1 year.
Do not take this medicine if any of the above
apply to you.

Preparatomtale

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Pericyazine 10mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Pericyazine 10mg
Excipients with known effect:
Methyl hydroxybenzoate: Each 10mg tablet contains 0.003 mg benzoate
salt.
Lactose: Each 10mg tablet contains 112.5mg lactose.
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Pericyazine 10mg Tablets: Circular, very pale lime-yellow tablet, with
one
face impressed ‘S172’ and a break-line on reverse.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
a)
In adults with schizophrenia or other psychoses, for the treatment of
symptoms or
prevention of relapse.
b)
In anxiety, psychomotor agitation, violent or dangerously impulsive
behaviour.
Pericyazine is used as an adjunct to the short-term management of
these conditions.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Route of administration_: oral .
Dosage requirement varies with the individual and the severity of the
condition being
treated. Initial dosage should be low with progressive increases until
the desired
response is obtained, after which dosage should be adjusted to
maintain control of the
symptoms.
_ Severe conditions _
_Indication (a) _
_ _
Adults:_ _Initially 75 mg per day in divided doses. Dosage should be
increased
by 25 mg per day at weekly intervals until the optimum effect is
achieved.
Maintenance therapy would not normally be expected to exceed 300 mg
per
day.
Elderly: _ _Initially 15-30 mg per day in divided doses. If this is
well tolerated
the dosage may be increased if necessary for optimum control of
behaviour.
_Mild or moderate conditions _
_ _
_Indication (b) _
_ _
Adults: Initially 15-30 mg daily, divided into two portions with a
larger dose
being given in the evening.
Elderly: 5-10 mg per day is suggested as a starting dose. It may be
divided so
that a larger portion is given in the evening. Half or quarter the
normal adult
dose may be sufficient for maintenance therapy.
Pericyazine tablets are not recommended for children.
4.3
CONTRAINDI